The rupee devaluation has had a negative impact on the competitiveness of Pakistan’s pharmaceutical industry. The industry in Pakistan is local-market oriented due to significant barriers of entry to the export market. The devaluation makes pharma products less attractive to foreign purchasers. There are stringent regulations being placed by DRAP in terms of pricing which are somewhat affecting the industry adversely.
Pharmaceutical companies cannot meet their expenses from the current pricing structure because of which they are bound to demand an increase in price. These companies also have to import specific active pharma ingredients in order to manufacture medicine. This means it costs more to produce a pill in rupees which leads to lower margins and competitiveness in the market due to devaluation. The decrease and slowing down on the competition, however, is beneficial to the public, and to an extent, to the pharma industry. Therefore, having a rate which is feasible for both the industry and public is a better option.
Mehr Aftab
Toronto, Canada
Cities and their suburbs or satellite towns ought to be celebrated for their modern amenities and cleanliness....
This letter refers to the news report ‘Rules being amended to remove upper age bar to hire top professionals’ . In...
In response to an earlier Israeli attack on its diplomatic facilities in Syria, Iranian forces retaliated by firing...
In most democratic states, the executive is often subordinate to the legislature in word and deed. Pakistan,...
In today's world, with all the amazing technology and progress we see, you might think people are really growing and...
India, often touted as the world's largest democracy, will begin holding its general elections from April 19. The BJP...